News
A Fife woman living with stage four incurable cancer is set to take on Sir Chris Hoy’s cycling challenge in Glasgow. At the ...
Rae Hyndman was diagnosed with advanced ovarian cancer in November 2023, after noticing bloating in her stomach.
Ovarian cancer isn't silent - learn the early warning signs. Persistent bloating, pelvic pain, urinary symptoms revealed.
New research has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body's immune response in advanced ovarian cancer. The findings offer new ...
Patients with high-risk advanced ovarian cancer obtained a marginal survival benefit with the addition of bevacizumab (Avastin) to first-line chemotherapy, while patients without high risk did not ...
Led by Ludwig Princeton's Lydia Lynch and reported in the current issue of Science Immunology, the study details how ascites fluid-produced in large quantities as ovarian cancer spreads from the ...
Gynecological cancers, including cervical, ovarian, uterine, vaginal, and vulvar cancers, affect the female reproductive system with varying symptoms.
This year is expected to see about 12,730 ovarian cancer-related deaths and some 20,890 diagnoses in the U.S. alone, according to Merck.
Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves—insights that could help researchers develop more effective treatment strategies.
July 7, 2010 — Trabectedin (Yondelis) has been approved in Europe, Canada, and other regions of the world for use in platinum-sensitive recurrent ovarian cancer, but it is not available in the ...
Novel drug combinations that improve survival outcomes, questions about treatment sequence, and encouraging results in chemo-resistant disease are highlights in ovarian cancer from ASCO 2025.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results